Novo Eyes Global-First Japan Approval For Concizumab

First Filing For Hemophila A/B Candidate

Concizumab can provide a new option for hemophilia A and B, Novo Nordisk says
Pen-Shaped Injector One Differentiator For Concizumab? • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Japan

More from Focus On Asia